The Recall Desk
Agency classClass IOur severity:SevereFDA (Devices)·Z-1903-2013·Announced 2013-08-21

Nova Max Plus Glucose Monitor Kits Recalled for False High Readings

Nova Biomedical is recalling Nova Max Plus Monitor Systems because test strips may produce false abnormally high glucose readings.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "Reports of false abnormally high glucose readings from test strips"

Plain-English summary

Nova Biomedical Corporation is recalling the Nova Max Plus Monitor System (Kit w/10 Count Vials), Catalog Number 43435. The recall involves 1,316,420 kits distributed nationwide in the United States and in Chile, England, Peru, and Nicaragua. The affected lots have expiration dates ranging from October 31, 2013, to April 30, 2015.

The recall was initiated due to reports of false abnormally high glucose readings from the test strips. These strips are intended for the quantitative measurement of glucose in fresh capillary whole blood for people with diabetes mellitus in the home and by healthcare professionals in clinical settings.

Consumers should stop using the affected test strips and contact Nova Biomedical Corporation for further instructions or a refund.

The recalled product

Product
Nova Max Plus Monitor System (Kit w/10 Count Vials) Catalog Number: 43435 Product usage: The Nova Max Glucose Test Strips are for use with the Nova Max Family of Glucose Monitors (Nova Max, Nova Max Plus, Nova Max Link, BD Logic and Paradigm Link). These monitors are…
Affected units
1,316,420

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 10 recalled by Nova Biomedical Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 10 products in this recall →

Similar recalls